Microfluidic Blood Typing via Stratified Laminar Flow
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current blood typing methods are labor-intensive, require specialized equipment and skilled technicians, and often result in delayed or inaccurate results due to the need for washed red cells, complex reagent handling, and exposure to infectious materials, especially when dealing with 'incomplete' antibodies or weak agglutination reactions.
Innovation Solution
A microfluidic device utilizing a horizontally-stratified laminar fluid diffusion interface with passive capillary flow control, allowing whole blood to be tested without special incubation conditions or equipment, where the flow rate is modulated to enhance antigen-antibody interactions, enabling rapid detection of agglutination reactions by sustaining low Reynolds Number flow for extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual blood typing methods using washed red cells and liquid reagents are used, then blood typing can be performed, but the process becomes labor-intensive, time-consuming, and requires skilled technicians
Solution Approach 1:
The patent employs a disposable microfluidic cartridge that integrates all testing components (reaction chambers, reagent reservoirs, flow channels) into a single-use device. This eliminates the need for complex manual procedures, washed red cell preparation, and specialized equipment while maintaining reliable results. The cartridge is discarded after one use, preventing cross-contamination and eliminating cleaning/maintenance requirements.
Solution Approach 2:
The invention merges multiple functions (reagent storage, sample processing, reaction, and detection) into a single integrated microfluidic cartridge. This consolidation simplifies the testing procedure by eliminating separate steps for cell washing, reagent mixing, and incubation, thereby reducing labor requirements and technical skill needs while preserving diagnostic accuracy.
2Measurement precision
If controlled heating and centrifugation are used to improve agglutination reactions, then detection sensitivity improves, but equipment requirements and operational complexity increase
Solution Approach 1:
The microfluidic cartridge is designed to perform agglutination reactions at ambient temperature without requiring external heating equipment or centrifugation devices. The device's passive fluid handling and reaction chambers are engineered to facilitate adequate mixing and reaction conditions naturally, eliminating the need for specialized equipment while maintaining sufficient detection sensitivity for clinical use.
3Reliability
If tube and slide test methods are used for blood typing, then blood group detection can be performed, but technicians are exposed to infectious materials and additional overhead is required
Solution Approach 1:
The disposable microfluidic cartridge completely encloses the blood sample and reagents within sealed chambers and flow channels. This closed-system design prevents technician exposure to infectious materials throughout the entire testing process, from sample loading to result interpretation. The cartridge is discarded after use, eliminating cross-contamination risks and biohazard disposal concerns associated with reusable tubes and slides.
Solution Approach 2:
The cartridge employs sealed membranes and flexible barriers to contain biological materials within the microfluidic circuitry. These barriers maintain sample containment while allowing optical detection of agglutination reactions through transparent or translucent sections, thus protecting users from exposure while preserving detection capability.
4Productivity
If pre-donation screening for ABO blood type is implemented, then blood bank efficiency improves and wastage reduces, but additional testing time and resources are required before donation
Solution Approach 1:
The invention extracts the blood typing function from the post-donation processing workflow and performs it immediately at the point of donation using the rapid microfluidic cartridge. This allows blood banks to identify compatible donors and allocate blood products proactively, reducing wastage of typed blood units while minimizing the time added to the donation process through the device's rapid testing capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for rapid, self-contained blood typing and crossmatching within two minutes, reducing errors and improving the efficiency of blood donation and transfusion management by enhancing the sensitivity and speed of antigen-antibody reactions, while minimizing exposure to biohazards.
Implementation Method 1
Two fluid streams are contacted in a laminar flow reaction channel and flow side-by-side in parallel or in anti-parallel directions without turbulent mixing
Implementation Method 2
The reaction channel typically has a dimension sufficiently small to induce laminar flow of the streams and a length and interfacial surface area between streams sufficient to allow diffusion of a solute from the sample stream into the reagent stream
Implementation Method 3
A microfluidic device utilizing a horizontally-stratified laminar fluid diffusion interface with passive capillary flow control
Data Source
AI summary
Microfluidic cartridges for agglutination reactions are provided. The cartridges include a microfluidic reaction channel with at least two intake channels, one for an antigen-containing fluid and the other for an antibody-containing fluid, conjoined to a reaction channel modified by incorporation of a downstream flow control channel. At low Reynolds Number, the two input streams layer one on top of the other in the reaction channel and form a flowing, unmixed horizontally-stratified laminar fluid diffusion (HLFD) interface for an extended duration of reaction. Surprisingly, the design, surface properties, and flow regime of microfluidic circuits of the present invention potentiate detection of antibody mediated agglutination at the stratified interface. Antigen:antibody reactions involving agglutination potentiated by these devices are useful in blood typing, in crossmatching for blood transfusion, and in immunodiagnostic agglutination assays, for example.